scholarly article | Q13442814 |
P50 | author | Jonas Mattsson | Q44779136 |
P2093 | author name string | Olle Ringdén | |
Mehmet Uzunel | |||
Marie Jaksch | |||
P2860 | cites work | Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv | Q38328321 |
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. | Q38455373 | ||
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. | Q53349829 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 788-794 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia | |
P478 | volume | 122 |
Q36997720 | Allogeneic transplantation for childhood ALL. |
Q37227738 | Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells |
Q81306380 | B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL |
Q38105123 | Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation |
Q47209362 | Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. |
Q52632345 | Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease. |
Q48109702 | Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India |
Q37601706 | Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival |
Q48028225 | Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation |
Q38681322 | Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia |
Q36726108 | Methods of minimal residual disease (MRD) detection in childhood haematological malignancies |
Q43014298 | NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All |
Q39106254 | Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. |
Q49894494 | Photochemotherapy and Graft-versus-Leukemia Reaction in Acute Leukemia: Tumor Immunity and Survival Are Dependent on Timing of Photochemotherapy of the Skin |
Q35100974 | Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation |
Q37628681 | Recent advances in quantitative chimerism analysis |
Q33886177 | Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia. |
Q41844565 | Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring |
Q41688221 | The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation |
Q54627391 | Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. |
Search more.